Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
22-Feb-2021
Nyrada Reports Half Year FY2021 Results
22-Feb-2021
Appendix 4D and Half Year Accounts
16-Feb-2021
Lapsing of balance of Unlisted SAB Options
16-Feb-2021
Cleansing Statement
16-Feb-2021
Appendix 2A
1-Feb-2021
NYR Secures Collaboration with Walter Reed and UNSW
29-Jan-2021
Trading Halt
28-Jan-2021
Nyrada Quarterly Activities Report & Appendix 4C
25-Jan-2021
Nyrada Reports Further Results from Cholesterol Study
22-Jan-2021
Unlisted Scientific Advisory Board Options Expiry 15 Feb 21
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Next